Jul 24, 2026
FDA Advisory Panel Votes to Back BPC-157 and KPV for Compounding
An FDA advisory committee voted 8 to 6, with one abstention, to recommend that BPC-157 and KPV be added to the 503A list of substances pharmacies can legally compound. The panel sided against the agency's own staff, who had recommended no. The vote is a recommendation, not a rule, and here is what it does and does not change.